BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 10631194)

  • 1. Frequent estrogen and progesterone receptor immunoreactivity in renal angiomyolipomas from women with pulmonary lymphangioleiomyomatosis.
    Logginidou H; Ao X; Russo I; Henske EP
    Chest; 2000 Jan; 117(1):25-30. PubMed ID: 10631194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent progesterone receptor immunoreactivity in tuberous sclerosis-associated renal angiomyolipomas.
    Henske EP; Ao X; Short MP; Greenberg R; Neumann HP; Kwiatkowski DJ; Russo I
    Mod Pathol; 1998 Jul; 11(7):665-8. PubMed ID: 9688188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β-Catenin is a useful adjunct immunohistochemical marker for the diagnosis of pulmonary lymphangioleiomyomatosis.
    Flavin RJ; Cook J; Fiorentino M; Bailey D; Brown M; Loda MF
    Am J Clin Pathol; 2011 May; 135(5):776-82. PubMed ID: 21502434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The TSC-2 product tuberin is expressed in lymphangioleiomyomatosis and angiomyolipoma.
    Johnson SR; Clelland CA; Ronan J; Tattersfield AE; Knox AJ
    Histopathology; 2002 May; 40(5):458-63. PubMed ID: 12010366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of estrogen and progesterone receptors in the abnormal smooth muscle cells in pulmonary lymphangioleiomyomatosis following therapy. An immunohistochemical study.
    Matsui K; Takeda K; Yu ZX; Valencia J; Travis WD; Moss J; Ferrans VJ
    Am J Respir Crit Care Med; 2000 Mar; 161(3 Pt 1):1002-9. PubMed ID: 10712355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent [corrected] hyperphosphorylation of ribosomal protein S6 [corrected] in lymphangioleiomyomatosis-associated angiomyolipomas.
    Robb VA; Astrinidis A; Henske EP
    Mod Pathol; 2006 Jun; 19(6):839-46. PubMed ID: 16575396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In pulmonary lymphangioleiomyomatosis expression of progesterone receptor is frequently higher than that of estrogen receptor.
    Gao L; Yue MM; Davis J; Hyjek E; Schuger L
    Virchows Arch; 2014 Apr; 464(4):495-503. PubMed ID: 24570392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary lymphangioleiomyomatosis. A study of 69 patients. Groupe d'Etudes et de Recherche sur les Maladies "Orphelines" Pulmonaires (GERM"O"P).
    Urban T; Lazor R; Lacronique J; Murris M; Labrune S; Valeyre D; Cordier JF
    Medicine (Baltimore); 1999 Sep; 78(5):321-37. PubMed ID: 10499073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estradiol and tamoxifen stimulate LAM-associated angiomyolipoma cell growth and activate both genomic and nongenomic signaling pathways.
    Yu J; Astrinidis A; Howard S; Henske EP
    Am J Physiol Lung Cell Mol Physiol; 2004 Apr; 286(4):L694-700. PubMed ID: 12922981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary lymphangioleiomyomatosis and multiple hepatic angiomyolipomas in a man.
    Kim NR; Chung MP; Park CK; Lee KS; Han J
    Pathol Int; 2003 Apr; 53(4):231-5. PubMed ID: 12675767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of pulmonary lymphangioleiomyomatosis using a GnRH agonist].
    Desurmont S; Bauters C; Copin MC; Dewailly D; Tonnel AB; Wallaert B
    Rev Mal Respir; 1996 Jul; 13(3):300-4. PubMed ID: 8765924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal angiomyolipoma in association with pulmonary lymphangioleiomyomatosis.
    De Pauw RA; Boelaert JR; Haenebalcke CW; Matthys EG; Schurgers MS; De Vriese AS
    Am J Kidney Dis; 2003 Apr; 41(4):877-83. PubMed ID: 12666075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coexistence of pulmonary lymphangioleiomyomatosis and pulmonary angiomyolipoma.
    Sun X; Feng R; Zhang Y; Shi J; Xu KF
    BMC Pulm Med; 2016 Aug; 16(1):120. PubMed ID: 27527652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen receptor is significantly associated with the epithelioid variants of renal angiomyolipoma: a clinicopathological and immunohistochemical study of 67 cases.
    Cho NH; Shim HS; Choi YD; Kim DS
    Pathol Int; 2004 Jul; 54(7):510-5. PubMed ID: 15189505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features of lymphangioleiomyomatosis complicated by renal angiomyolipomas.
    Mizushina Y; Bando M; Hosono T; Mato N; Nakaya T; Ishii Y; Yamasawa H; Sugiyama Y
    Intern Med; 2011; 50(4):285-9. PubMed ID: 21325759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An unusual renal angiomyolipoma with morphological lymphangioleiomyomatosis features and coexpression of oestrogen and progesterone receptors.
    Colombat M; Boccon-Gibod L; Carton S
    Virchows Arch; 2002 Jan; 440(1):102-4. PubMed ID: 11942568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-gamma-Jak-Stat signaling in pulmonary lymphangioleiomyomatosis and renal angiomyolipoma: a potential therapeutic target.
    El-Hashemite N; Kwiatkowski DJ
    Am J Respir Cell Mol Biol; 2005 Sep; 33(3):227-30. PubMed ID: 15994429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-cell co-regulatory molecule expression in renal angiomyolipoma and pulmonary lymphangioleiomyomatosis.
    Boorjian SA; Sheinin Y; Crispen PL; Lohse CM; Leibovich BC; Kwon ED
    Urology; 2009 Dec; 74(6):1359-64. PubMed ID: 19501877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urokinase-type plasminogen activator (uPA) is critical for progression of tuberous sclerosis complex 2 (TSC2)-deficient tumors.
    Stepanova V; Dergilev KV; Holman KR; Parfyonova YV; Tsokolaeva ZI; Teter M; Atochina-Vasserman EN; Volgina A; Zaitsev SV; Lewis SP; Zabozlaev FG; Obraztsova K; Krymskaya VP; Cines DB
    J Biol Chem; 2017 Dec; 292(50):20528-20543. PubMed ID: 28972182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary lymphangiomyomatosis and kidney angiomyolipomas.
    Callol L; Villegas Fernandez FR; Calderon Alvarez J; Chillon MD; Gomez-Terreros FJ
    Respiration; 1993; 60(5):311. PubMed ID: 8284531
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.